A CSC gene signature from comparative analysis of CD44+CD24− sorted tumor cells and cancer mammospheres showed that this signature was associated with claudin-low breast cancers, suggesting that claudin-low tumors are enriched for CSCs (Creighton et al., 2009). The gene discussed is CD44; the disease is breast cancer.